Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Protect Children From The Allure Of Smoking, Say Doctors
BMA Scotland has warned that children who smoke face years of tobacco addiction that can lead to life-threatening diseases and premature death. The association also called on MSPs to support the proposals contained in the Tobacco and Primary Medical services (Scotland) Bill in order to reduce children"s exposure to tobacco products.
generic viagra online
Polymorphism In Endostatin, An Angiogenesis Inhibitor, And Prostate Cancer Risk And Survival: A Prospective Study
UroToday.com - Angiogenesis is the process of new blood vessel formation in tumors, facilitating their growth. Endostatin is a cleavage product of collagen and is a potent inhibitor of endothelial cell proliferation and migration. Endostatin causes apoptosis in endothelial and tumor cells. Prostate cancer expresses angiogenic factors.
plastic surgery before after
News of the day
How To Confirm The Causes Of Iron Deficiency Anemia In Young Women
Iron-deficiency anaemia (IDA) is commonly seen in women aged under 50 years. The diagnostic workflow in young women affected by IDA is not clearly established. The British Society of Gastroenterology recommends gastroscopy only in IDA women younger than 45 years presenting with gastrointestinal (GI) symptoms. However, symptoms are often mild and aspecific in IDA women and the gastroscopy is an invasive procedure associated with a high number of refusals. In a previous work on IDA premenopausal women, gastroscopy was performed in all patients, later deemed unnecessary in almost 30% of the studied women because these were affected only by menorrhagia.
Mental Health

Southampton Asthma Researchers Win Share Of EU Grant, UK

Southampton researchers studying the treatment of severe asthma have won a share of a 23m euro grant. Experts at the city"s Respiratory Biomedical Research Unit (BRU), based at Southampton General Hospital, are among a consortium of 14 European academic centres of excellence to receive a slice of the funding. The BRU, a partnership between Southampton University Hospitals NHS Trust and the University of Southampton, will use its share to pursue research into severe asthma, using methods developed in Southampton"s renowned lipid and protein research centres. The funding comes as part of a major investment drive by the European Union called Innovative Medicines Initiative (IMI), which is designed to remove bottlenecks in the discovery and development of new drugs. The project means that, for the first time, academics will work closely and comprehensively with pharmaceutical companies and enterprises to quickly progress drug development. Professor Ratko Djukanovic, director of the Southampton National Institute for Health Research BRU, was one of three initiators of the programme. He said: "Academics from different universities often work together to complement expertise and enhance research projects, but this is the first time they have joined forces with large pharma companies and enterprises to create a cohesive team. "Critically, the discoveries from this programme will be publicly owned and immediately made available for the benefit of all." The work to be conducted in Southampton will play a key role in the definition of new subsets of asthma and will take advantage of the state-of-the art research facilities on offer at the city"s university hospitals. Dr Michael Marsh, SUHT medical director, said: "The partnership between the Trust and the UoS is a real success, which is clear from our joint selection as venues for two leading BRUs, one in respiratory medicine and the other in nutrition. "Such status has enabled us to become part of this unique consortium and take a share of the research grant, making this Trust one of the best places for clinicians and scientists to work together for the direct benefit of patients." Professor Iain Cameron, head of the school of medicine, added: "This is a great achievement for Southampton. Not only does it reflect the excellent research conducted in Southampton, but also shows the benefits of close integration of scientists and clinicians across the University and SUHT and enhances our international reputation." Southampton University Hospitals NHS Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009